You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Age-Related Lymphocyte and Neutrophil Levels in Children of Hepatitis C-Infected Women

Pembrey, Lucy PhD*; Newell, Marie-Louise PhD*†; Tovo, Pier-Angelo MD‡; European Paediatric Hepatitis C Virus Network

Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e31816ffc0e
Original Studies
Abstract

Background: Investigation of immunologic values in children vertically exposed to hepatitis C virus (HCV) infection could help explain the higher risk of infection in girls and indicate mechanisms of spontaneous viral clearance and possible long-term immunologic effects.

Methods: Prospective study of children born to HCV-infected women. Lymphocyte and neutrophil measurements were age-standardized using the LMS method (this summarizes the changing age distribution of a variable). Associations between maternal and infant characteristics and lymphocyte and neutrophil z-scores were quantified using linear regression allowing for repeated measures.

Results: HCV-infected children, girls, and those born to HCV/human immunodeficiency virus (HIV)-coinfected women had significantly higher lymphocyte z-scores than HCV-uninfected children, boys, and children born to HCV-only-infected women, respectively. Peak absolute lymphocytes were significantly lower for infected children with evidence of viral clearance than for persistently infected children. Girls also had significantly higher neutrophil z-scores than boys but HCV-infected children had significantly lower neutrophil z-scores than uninfected children.

Conclusions: The gender associations are in line with those observed among children born to HIV-infected women, suggesting general gender-based differences in response to infection. Age-related standards for uninfected children could be used to assess immune function in other pediatric diseases and these results suggest that gender-specific reference values should be used at least for the first 2 years of life.

Author Information

From the *Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health and Great Ormond Hospital for Children NHS Trust, University College London, London, UK; †Africa Centre for Health and Population Studies, University of KwaZulu Natal, Somkhele, South Africa; and ‡Dipartimento di Scienze Pediatriche e dell’ Adolescenza, Università degli Studi di Torino, Torino, Italy.

Accepted for publication February 22, 2008.

Lucy Pembrey was funded by a U.K. Medical Research Council Special Research Training Fellowship in Health Services and Health of the Public Research.

The European Pediatric HCV Network was funded by a European Commission concerted action grant–Quality of Life and Management of Living Resources Programme, contract number: QLK2-CT-2001-01165.

Address for correspondence: Lucy Pembrey, PhD, Infectious Disease Epidemiology Unit, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT. E-mail: lucy.pembrey@lshtm.ac.uk.

Additional material related to this article and only published online can be accessed on the Web by clicking on the “ArticlePlus” link either in the Table of Contents or at the top of the Abstract or HTML version of the article.

© 2008 Lippincott Williams & Wilkins, Inc.